RecruitingNot ApplicableNCT06735001

Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention

Sponsor

University Hospital, Bordeaux

Enrollment

400 participants

Start Date

Mar 10, 2025

Study Type

INTERVENTIONAL

Conditions

Atrial Fibrillation (AF)

Summary

Atrial fibrillation (AF) is a major public health problem. The efficacy of the existing techniques is limited in the more aggressive forms. It is therefore necessary to develop approaches, in particular the identification of relevant biomarkers, to prevent the onset, recurrence or progression of AF in at-risk patients. The objective of this study is to describe the longitudinal metabolic and biomolecular signature of AF in patients eligible for cardiac ablation.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Age ≥ 18 years, all genders, and ethnic origins
Free, informed, and written consent signed
Person affiliated to or benefiting from a social security scheme

Exclusion Criteria9

Age \< 18 years
Lack of informed consent
Gestating women (pregnancy test carried out as part of care for FA patients, contraception, or menopause for women in control groups)
Persons under administrative or judicial protection
Endocarditis or pericarditis in progress or within the 3 last months
Active tumor pathology (benign or malignant)
Chronic inflammation or autoimmune disease
Chronic liver disease
Myocardial infarction within the last 8 weeks